Michael Thomas Heffernan - Insider Trading & Ownership

Entity
Individual
Location
C/O Cornerstone Therapeutics Inc., 1255 Crescent Green Drive, Suite 250, Cary, NC
Summary
The estimated net worth of Michael Thomas Heffernan is at least $1.53M dollars as of June 14, 2024. Michael Thomas Heffernan is the Director of COLLEGIUM PHARMACEUTICAL, INC and owns shares of COLLEGIUM PHARMACEUTICAL, INC (COLL) stock worth about $1.47M. Michael Thomas Heffernan is the Director of Akebia Therapeutics, Inc. and owns shares of Akebia Therapeutics, Inc. (AKBA) stock worth about $59.4K.
All Insider Reports
All Insider Reports

Ownership of Michael Thomas Heffernan

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
COLL COLLEGIUM PHARMACEUTICAL, INC Director $1.47M May 16, 2024
AKBA Akebia Therapeutics, Inc. Director $59.4K Jun 2, 2021
BHVN Biohaven Ltd. Director Apr 30, 2024
BHVN Biohaven Pharmaceutical Holding Co Ltd. Director Oct 3, 2022
SYBX SYNLOGIC, INC. Director Jun 22, 2023
TRVI Trevi Therapeutics, Inc. Director Jun 13, 2024

Insider Transactions Reported by Michael Thomas Heffernan:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.